Fuji Pharma Co (FRA:FUP) E10: €0.69 (As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
84 GF Score
Price €11.60
GF Value €9.61
! 5 Warning Signs
View Full Analysis

What is Fuji Pharma Co E10?

Fuji Pharma Co FRA:FUP -6.45% 84 E10 is €0.69 as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 84/100 and a GF Value™ of €9.61. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fuji Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.084. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fuji Pharma Co's average E10 Growth Rate was 2.40% per year. During the past 3 years, the average E10 Growth Rate was 12.10% per year. During the past 5 years, the average E10 Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fuji Pharma Co was 13.40% per year. The lowest was 0.90% per year. And the median was 6.60% per year.

As of today (2026-06-26), Fuji Pharma Co's current stock price is €11.60. Fuji Pharma Co's E10 for the quarter that ended in Mar. 2026 was €0.69. Fuji Pharma Co's Shiller PE Ratio of today is 16.81.

During the past 13 years, the highest Shiller PE Ratio of Fuji Pharma Co was 24.81. The lowest was 10.11. And the median was 13.67.


Fuji Pharma Co  (FRA:FUP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fuji Pharma Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=11.60/0.69
=16.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Fuji Pharma Co was 24.81. The lowest was 10.11. And the median was 13.67.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fuji Pharma Co E10 Related Terms


Fuji Pharma Co E10 Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co E10 Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.63 0.62 0.75 0.73

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.73 0.73 0.69 0.69

FRA:FUP vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuji Pharma Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's Shiller PE Ratio falls into.


FRA:FUP
84GF Score
Fuji Pharma Co Ltd FRA:FUP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fuji Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.084/112.7000*112.7000
=0.084

Current CPI (Mar. 2026) = 112.7000.

Fuji Pharma Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.167 98.100 0.192
201609 0.133 98.000 0.153
201612 0.294 98.400 0.337
201703 0.197 98.100 0.226
201706 0.241 98.500 0.276
201709 0.155 98.800 0.177
201712 0.325 99.400 0.368
201803 0.113 99.200 0.128
201806 0.224 99.200 0.254
201809 0.196 99.900 0.221
201812 0.287 99.700 0.324
201903 0.159 99.700 0.180
201906 0.217 99.800 0.245
201909 0.117 100.100 0.132
201912 0.197 100.500 0.221
202003 -0.117 100.300 -0.131
202006 0.332 99.900 0.375
202009 0.134 99.900 0.151
202012 0.338 99.300 0.384
202103 0.201 99.900 0.227
202106 0.192 99.500 0.217
202109 -0.066 100.100 -0.074
202112 0.358 100.100 0.403
202203 0.226 101.100 0.252
202206 0.235 101.800 0.260
202209 0.016 103.100 0.017
202212 0.321 104.100 0.348
202303 0.189 104.400 0.204
202306 0.056 105.200 0.060
202309 0.379 106.200 0.402
202312 0.718 106.800 0.758
202403 0.383 107.200 0.403
202406 0.158 108.200 0.165
202409 0.321 108.900 0.332
202412 0.253 110.700 0.258
202503 0.075 111.100 0.076
202506 0.133 111.700 0.134
202509 0.276 112.000 0.278
202512 0.073 113.000 0.073
202603 0.084 112.700 0.084

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.69 mean?
Fuji Pharma Co (FRA:FUP) has a E10 of €0.69 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fuji Pharma Co and its competitors.
Is Fuji Pharma Co's E10 too high?
Fuji Pharma Co's current E10 is €0.69. Overall, Fuji Pharma Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's E10 compare to ZTS?
Fuji Pharma Co's E10 of €0.69 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fuji Pharma Co and its competitors. Fuji Pharma Co's current E10 is €0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current E10 of €0.69. The stock's GF Value™ is €9.61, compared to a current price of €11.60 — trading 20.7% above its estimated fair value. The current E10 is €0.69. Fuji Pharma Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current E10 is €0.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €11.60 is trading 20.7% above its estimated GF Value™ of €9.61.

Key valuation signals for FRA:FUP:

  • E10: €0.69
  • GF Value™: €9.61 vs. price of €11.60 (20.7% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
84GF Score

Get the complete analysis for FRA:FUP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price
€9.61
GF Value